Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients.

Journal of viral hepatitis - 1 Feb 2015

Chowdhury S J, Karra V K, Gumma P K, Bharali R, Kar P

Abstract excerpt

The basis of response of chronic hepatitis C (CHC) patients to treatment is still unclear, and there may be many other factors which influence treatment outcome other than the existing ones. The serum concentration of C3 closely reflects the total complement activity, and individuals affected by C3 deficiency suffer from recurrent pyogenic infections. This study aims to find out relationship between levels of C3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Complement C3
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Ribavirin

Source

Identifiers

PMID: 24995942
DOI: 10.1111/jvh.12280

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients.PMID 24995942Read ↗

Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients.Semantic proximity Read ↗

Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects.Semantic proximity Read ↗

Association of Interferon Regulatory Factor-3 gene polymor- phisms with infection and antiviral efficacy of chronic hepatitis C virusSemantic proximity Read ↗

The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinomaSemantic proximity Read ↗

Interferon Lambda-3 rs12979860 Variants and Response to Pegylated Interferon in Chronic Hepatitis-C Genotype-3.Semantic proximity Read ↗

The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern IranSemantic proximity Read ↗

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3.Semantic proximity Read ↗

The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.Semantic proximity Read ↗

Genetic Polymorphism in Toll-Like Receptor 3 and Interferon Regulatory Factor 3 in Hepatitis C Virus-Infected Patients: Correlation with Liver Cirrhosis.Semantic proximity Read ↗

[Current status, treatment and prospect of patients with chronic hepatitis C genotype 3 in China].Semantic proximity Read ↗

Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.